June 4 - 6, 2012    San Francisco CA , USA
Single-use technology for biopharm manufacturing is no longer a debate - almost everyone knows of its economic and fast product changeover benefits. However, what's tailing behind is the technology development, especially for downstream processing and single-use probes/sensors. What are some of the latest development and alternatives in chromatography? How can vendors make sensors more sensitive? Is the issue of extractables & leachables well resolved? How are companies integrating single-use into a stainless steel facility to increase productivity? Besides antibodies, proteins and vaccines, what's the uptake of single-use technologies in the production of cell therapies and biosimilars?

Venue

Location: The Westin San Francisco Market Street
Contact 50 3rd St. San Francisco , USA